Article and Video CATEGORIES
Chief of Hematology/Oncology and Medical Director at Memorial Cancer Institute, and Clinical Associate Professor of Medicine at Florida International University
Chief of Hematology/Oncology
Medical Director of Memorial Cancer Institute
We are pleased to offer additions to our Lung Cancer Video Library for our Spanish speaking community.
Para este año, además de nuestra videoteca de cáncer de pulmón producida en español para nuestra comunidad latina, el Dr. Luis Raez nos brinda información actualizada. En este video, el Dr. Raez analiza las nuevas terapias dirigidas para el NSCLC a la espera de aprobación (RET - Loxo 292 y Blu667).
Para unirse a la conversación, visite https://cancergrace.org/forum.
*****
For this years addition to our Lung Cancer Video Library produced in Spanish for our Latino Community, Dr. Luis Raez provides us with up to date information. In this video, Dr. Raez discusses new targeted therapies for NSCLC waiting for approval (RET – Loxo 292 and Blu667).
To join the conversation, visit https://cancergrace.org/forum.
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…